RLX Technology Inc vs 22nd Century Group Inc — how do they compare? RLX Technology Inc trades at $1.74 (market cap $2.10B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: RLX Technology Inc is far larger — about 3378× 22nd Century Group Inc's market cap, and RLX Technology Inc pays a 5.81% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold RLX Technology Inc for 35 Days and 22nd Century Group Inc for 32 Days on average.
| RLX | XXII | |
|---|---|---|
Market Cap | $2.10B | $621.67K |
Volume | 1,079,706 | 45,625 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $2.57 | $483.00 |
52-Week Low | $1.68 | $0.80 |
Typical Hold Time | 35 Days | 32 Days |
Enterprise Value | $832.26M | -$3.69M |
Dividend Yield | 5.81% | — |
Signals from Pluang's Aura AI — not financial advice
RLX Technology trades at $1.735, up 0.29% with bearish technical signals despite recent 52-week lows. The company shows solid fundamentals with $3.62B revenue, 21.87% net margin, and attractive valuation at P/E 15.46 and P/B 0.91. Recent earnings missed expectations but international expansion drives growth, with 70% revenue now from overseas markets. Cash flow trends improved significantly from -$99M in 2025 to $881M projected for 2026.
RLX presents a value opportunity with discounted valuation and strong international growth, though technical weakness and earnings misses warrant caution. The single analyst coverage maintains Hold rating, reflecting uncertainty amid expansion execution risks and regulatory challenges in the e-vapor industry.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →